🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

FMC gains Brazil registration for new herbicides

EditorLina Guerrero
Published 05/28/2024, 04:38 PM
© Reuters.
FMC
-

PHILADELPHIA - FMC Corporation (NYSE: NYSE:FMC), a prominent player in the global agricultural sciences industry, has announced that it has secured registration in Brazil for two herbicides, Azugro® and Ezanya®, intended for use in cotton, tobacco, and wheat crops. These products, containing the active ingredient bixlozone, marketed under the brand name Isoflex®, represent a new option for farmers dealing with herbicide-resistant weeds.

The registration of Azugro® and Ezanya® by Brazilian authorities provides farmers with additional resources to combat challenging weeds such as goosegrass and Italian ryegrass, as well as certain broadleaf species. Azugro® is slated for use in cotton in the 2024 crop season and wheat in 2025. Ezanya®, on the other hand, will be available for tobacco in the 2024 crop season.

Isoflex® active, the key ingredient in these herbicides, is classified as a Group 13 herbicide by the Herbicide Resistance Action Committee (HRAC) and is noted for its efficacy in cereal crops. The product has already been registered in other major agricultural markets including Argentina, Australia, and China, where it has been used with selectivity in pre-plant, pre-emergence, and early post-emergence applications across a variety of major crops.

FMC's Brazil business director, Sinara Ferreira, expressed confidence that the new herbicides will significantly aid growers by providing effective weed control solutions, particularly against herbicide-resistant weeds. The company continues to research the application of Isoflex® active products in other crops and market segments within Brazil.

InvestingPro Insights

FMC Corporation's recent announcement about securing registration for two new herbicides in Brazil is a testament to the company's ongoing commitment to innovation in agricultural sciences. As FMC continues to expand its global footprint, the financial health and market performance of the company remain crucial for investors.

InvestingPro data reveals that FMC has a market capitalization of $7.85 billion, with a strong P/E ratio of 6.97, indicating that the stock may be undervalued relative to its earnings. Additionally, the company's PEG ratio, which measures the price of a stock relative to its earnings growth, stands at an attractive 0.11 for the last twelve months as of Q1 2024, suggesting potential for future growth.

An InvestingPro Tip highlights that FMC has raised its dividend for 6 consecutive years, showcasing a commitment to returning value to shareholders. Moreover, the company has maintained dividend payments for 19 consecutive years, which may appeal to income-focused investors. The dividend yield as of the latest available data is 3.76%, with the ex-date of the last dividend being March 27, 2024.

Despite some analysts revising their earnings downwards for the upcoming period, FMC has demonstrated a strong return over the last three months, with a 21.54% price total return. This performance, coupled with a forecast of profitability for the year, could be a sign of resilience in the face of market challenges.

For investors interested in a deeper dive into the company's financials and future outlook, InvestingPro offers additional insights. There are 7 more InvestingPro Tips available, providing a broader analysis of FMC's financial health and market prospects. To explore these insights and make informed investment decisions, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at https://www.investing.com/pro/FMC.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.